Difficulty: Medium
Average Score: 86%
Practice
Select the drug which can improve urinary flow rate in benign prostatic hypertrophy without affecting prostate size
Correct answer
B
Rationale
The correct answer to the question is B) Prozosin. Prozosin is an alpha-1 adrenergic receptor blocker that helps improve urinary flow rate in benign prostatic hypertrophy (BPH) by relaxing the smooth muscles in the prostate and bladder neck without affecting the prostate size. This mechanism of action helps alleviate the symptoms of BPH, such as urinary hesitancy and frequency, by reducing the obstruction to urine flow.
Option A) Amphetamine is a central nervous system stimulant used for conditions like ADHD and narcolepsy. It does not have any specific effect on improving urinary flow in BPH.
Option C) Finasteride is a 5-alpha reductase inhibitor that helps reduce prostate size in BPH by blocking the conversion of testosterone to dihydrotestosterone. While it can help shrink the prostate and improve symptoms, it does not directly improve urinary flow rate without affecting prostate size.
Option D) Goserelin is a gonadotropin-releasing hormone agonist used in prostate cancer treatment to suppress testosterone production. It is not typically used to improve urinary flow rate in BPH.
Educationally, understanding the mechanisms of action of different drugs used in BPH treatment is crucial for healthcare professionals to make informed decisions in managing patients with this condition. Knowing the specific effects of each drug helps in selecting the most appropriate treatment based on the patient's symptoms and clinical presentation. This knowledge also aids in preventing medication errors and ensuring optimal patient outcomes.
Option A) Amphetamine is a central nervous system stimulant used for conditions like ADHD and narcolepsy. It does not have any specific effect on improving urinary flow in BPH.
Option C) Finasteride is a 5-alpha reductase inhibitor that helps reduce prostate size in BPH by blocking the conversion of testosterone to dihydrotestosterone. While it can help shrink the prostate and improve symptoms, it does not directly improve urinary flow rate without affecting prostate size.
Option D) Goserelin is a gonadotropin-releasing hormone agonist used in prostate cancer treatment to suppress testosterone production. It is not typically used to improve urinary flow rate in BPH.
Educationally, understanding the mechanisms of action of different drugs used in BPH treatment is crucial for healthcare professionals to make informed decisions in managing patients with this condition. Knowing the specific effects of each drug helps in selecting the most appropriate treatment based on the patient's symptoms and clinical presentation. This knowledge also aids in preventing medication errors and ensuring optimal patient outcomes.